APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Swine Influenza Vaccines Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchSwine Influenza Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Influenza Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Swine Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Influenza Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Influenza Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Swine Influenza Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Swine Influenza Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Swine Influenza Vaccines market include Boehringer Ingelheim, CAHIC, Ceva, DHN, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Ringpu Biology and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Influenza Vaccines Segment by Company

Boehringer Ingelheim

CAHIC

Ceva

DHN

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Ringpu Biology

Zoetis

Chengdu TECBOND

Swine Influenza Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Influenza Vaccines Segment by Application

Commodity Pig

Breeding Pig

Swine Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Swine Influenza Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Swine Influenza Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Swine Influenza Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Swine Influenza Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Influenza Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Swine Influenza Vaccines industry.

Chapter 3: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Swine Influenza Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Swine Influenza Vaccines Industry Trends Table 2. Swine Influenza Vaccines Industry Drivers Table 3. Swine Influenza Vaccines Industry Opportunities and Challenges Table 4. Swine Influenza Vaccines Industry Restraints Table 5. Global Swine Influenza Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Swine Influenza Vaccines Revenue Share by Company (2021-2026) Table 7. Global Swine Influenza Vaccines Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Swine Influenza Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Swine Influenza Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Swine Influenza Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Swine Influenza Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Swine Influenza Vaccines Company, Product Type & Application Table 13. Global Swine Influenza Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Killed Vaccines Table 19. Global Swine Influenza Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Swine Influenza Vaccines Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Swine Influenza Vaccines Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Swine Influenza Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Swine Influenza Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Swine Influenza Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Swine Influenza Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Swine Influenza Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Swine Influenza Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Swine Influenza Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Commodity Pig Table 30. Significant Companies of Breeding Pig Table 31. Global Swine Influenza Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Swine Influenza Vaccines Sales Volume by Application (2021-2026) & (M Units) Table 33. Global Swine Influenza Vaccines Sales Volume by Application (2027-2032) & (M Units) Table 34. Global Swine Influenza Vaccines Sales Volume Share by Application (2021-2026) Table 35. Global Swine Influenza Vaccines Sales Volume Share by Application (2027-2032) Table 36. Global Swine Influenza Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Swine Influenza Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Swine Influenza Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Swine Influenza Vaccines Sales Value Share by Application (2021-2026) Table 40. Global Swine Influenza Vaccines Sales Value Share by Application (2027-2032) Table 41. Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Swine Influenza Vaccines Sales by Region (2021-2026) & (M Units) Table 43. Global Swine Influenza Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Swine Influenza Vaccines Sales by Region (2027-2032) & (M Units) Table 45. Global Swine Influenza Vaccines Sales Market Share by Region (2027-2032) Table 46. Global Swine Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Swine Influenza Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Swine Influenza Vaccines Sales Value Share by Region (2021-2026) Table 49. Global Swine Influenza Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Swine Influenza Vaccines Sales Value Share by Region (2027-2032) Table 51. Global Swine Influenza Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Swine Influenza Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 54. Global Swine Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 56. Global Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 57. Global Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 58. Global Swine Influenza Vaccines Sales Market Share by Country (2027-2032) Table 59. Global Swine Influenza Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Swine Influenza Vaccines Sales Value Market Share by Country (2021-2026) Table 61. Global Swine Influenza Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Swine Influenza Vaccines Sales Value Market Share by Country (2027-2032) Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. CAHIC Company Information Table 69. CAHIC Business Overview Table 70. CAHIC Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. CAHIC Swine Influenza Vaccines Product Portfolio Table 72. CAHIC Recent Development Table 73. Ceva Company Information Table 74. Ceva Business Overview Table 75. Ceva Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ceva Swine Influenza Vaccines Product Portfolio Table 77. Ceva Recent Development Table 78. DHN Company Information Table 79. DHN Business Overview Table 80. DHN Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. DHN Swine Influenza Vaccines Product Portfolio Table 82. DHN Recent Development Table 83. Green Cross Veterinary Company Information Table 84. Green Cross Veterinary Business Overview Table 85. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Green Cross Veterinary Swine Influenza Vaccines Product Portfolio Table 87. Green Cross Veterinary Recent Development Table 88. Hipra Company Information Table 89. Hipra Business Overview Table 90. Hipra Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hipra Swine Influenza Vaccines Product Portfolio Table 92. Hipra Recent Development Table 93. MSD Animal Health (Merck) Company Information Table 94. MSD Animal Health (Merck) Business Overview Table 95. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio Table 97. MSD Animal Health (Merck) Recent Development Table 98. Ringpu Biology Company Information Table 99. Ringpu Biology Business Overview Table 100. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Ringpu Biology Swine Influenza Vaccines Product Portfolio Table 102. Ringpu Biology Recent Development Table 103. Zoetis Company Information Table 104. Zoetis Business Overview Table 105. Zoetis Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zoetis Swine Influenza Vaccines Product Portfolio Table 107. Zoetis Recent Development Table 108. Chengdu TECBOND Company Information Table 109. Chengdu TECBOND Business Overview Table 110. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Chengdu TECBOND Swine Influenza Vaccines Product Portfolio Table 112. Chengdu TECBOND Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Swine Influenza Vaccines Distributors List Table 116. Swine Influenza Vaccines Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Swine Influenza Vaccines Product Image Figure 2. Global Swine Influenza Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Swine Influenza Vaccines Sales (2021-2032) & (M Units) Figure 5. Global Swine Influenza Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Swine Influenza Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Killed Vaccines Image Figure 11. Global Swine Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Swine Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Swine Influenza Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Swine Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Swine Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Swine Influenza Vaccines Sales Value Share by Type (2021-2032) Figure 17. Commodity Pig Image Figure 18. Breeding Pig Image Figure 19. Global Swine Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Swine Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Swine Influenza Vaccines Sales Volume Share by Application (2021-2032) Figure 22. Global Swine Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Swine Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Swine Influenza Vaccines Sales Value Share by Application (2021-2032) Figure 25. Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 26. Global Swine Influenza Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Swine Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Swine Influenza Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 30. North America Swine Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Swine Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Swine Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. South America Swine Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Swine Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Swine Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Swine Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Swine Influenza Vaccines Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Swine Influenza Vaccines Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Commodity Pig
  • Breeding Pig
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • DHN
  • Green Cross Veterinary
  • Hipra
  • MSD Animal Health (Merck)
  • Ringpu Biology
  • Zoetis
  • Chengdu TECBOND

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Influenza Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Swine Influenza Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Swine Influenza Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Swine Influenza Vaccines Market Dynamics
  1. 2.1 Swine Influenza Vaccines Industry Trends
  2. 2.2 Swine Influenza Vaccines Industry Drivers
  3. 2.3 Swine Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Influenza Vaccines Industry Restraints
3 Swine Influenza Vaccines Market by Company
  1. 3.1 Global Swine Influenza Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Swine Influenza Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Swine Influenza Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Swine Influenza Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Swine Influenza Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Swine Influenza Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Swine Influenza Vaccines Company Product Type and Application
  8. 3.8 Global Swine Influenza Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Swine Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Swine Influenza Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Swine Influenza Vaccines Market by Type
  1. 4.1 Swine Influenza Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Swine Influenza Vaccines Sales Volume by Type
  5. 4.2.1 Global Swine Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Swine Influenza Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Swine Influenza Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Swine Influenza Vaccines Sales Value by Type
  9. 4.3.1 Global Swine Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Swine Influenza Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Swine Influenza Vaccines Sales Value Share by Type (2021-2032)
5 Swine Influenza Vaccines Market by Application
  1. 5.1 Swine Influenza Vaccines Application Introduction
  2. 5.1.1 Commodity Pig
  3. 5.1.2 Breeding Pig
  4. 5.2 Global Swine Influenza Vaccines Sales Volume by Application
  5. 5.2.1 Global Swine Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Influenza Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Swine Influenza Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Swine Influenza Vaccines Sales Value by Application
  9. 5.3.1 Global Swine Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Influenza Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Swine Influenza Vaccines Sales Value Share by Application (2021-2032)
6 Swine Influenza Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Influenza Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Influenza Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Swine Influenza Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Swine Influenza Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Swine Influenza Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Swine Influenza Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Swine Influenza Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Swine Influenza Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Swine Influenza Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Swine Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Swine Influenza Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Swine Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Swine Influenza Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Swine Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Swine Influenza Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Swine Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Swine Influenza Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Swine Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
7 Swine Influenza Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Swine Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Swine Influenza Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Swine Influenza Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Swine Influenza Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Swine Influenza Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Swine Influenza Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Swine Influenza Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Swine Influenza Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Swine Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Swine Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 CAHIC
  8. 8.2.1 CAHIC Company Information
  9. 8.2.2 CAHIC Business Overview
  10. 8.2.3 CAHIC Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CAHIC Swine Influenza Vaccines Product Portfolio
  12. 8.2.5 CAHIC Recent Developments
  13. 8.3 Ceva
  14. 8.3.1 Ceva Company Information
  15. 8.3.2 Ceva Business Overview
  16. 8.3.3 Ceva Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Swine Influenza Vaccines Product Portfolio
  18. 8.3.5 Ceva Recent Developments
  19. 8.4 DHN
  20. 8.4.1 DHN Company Information
  21. 8.4.2 DHN Business Overview
  22. 8.4.3 DHN Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DHN Swine Influenza Vaccines Product Portfolio
  24. 8.4.5 DHN Recent Developments
  25. 8.5 Green Cross Veterinary
  26. 8.5.1 Green Cross Veterinary Company Information
  27. 8.5.2 Green Cross Veterinary Business Overview
  28. 8.5.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
  30. 8.5.5 Green Cross Veterinary Recent Developments
  31. 8.6 Hipra
  32. 8.6.1 Hipra Company Information
  33. 8.6.2 Hipra Business Overview
  34. 8.6.3 Hipra Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hipra Swine Influenza Vaccines Product Portfolio
  36. 8.6.5 Hipra Recent Developments
  37. 8.7 MSD Animal Health (Merck)
  38. 8.7.1 MSD Animal Health (Merck) Company Information
  39. 8.7.2 MSD Animal Health (Merck) Business Overview
  40. 8.7.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
  42. 8.7.5 MSD Animal Health (Merck) Recent Developments
  43. 8.8 Ringpu Biology
  44. 8.8.1 Ringpu Biology Company Information
  45. 8.8.2 Ringpu Biology Business Overview
  46. 8.8.3 Ringpu Biology Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
  48. 8.8.5 Ringpu Biology Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Swine Influenza Vaccines Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Chengdu TECBOND
  56. 8.10.1 Chengdu TECBOND Company Information
  57. 8.10.2 Chengdu TECBOND Business Overview
  58. 8.10.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
  60. 8.10.5 Chengdu TECBOND Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Influenza Vaccines Value Chain Analysis
  2. 9.1.1 Swine Influenza Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Influenza Vaccines Sales Mode & Process
  6. 9.2 Swine Influenza Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Influenza Vaccines Distributors
  9. 9.2.3 Swine Influenza Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst